Sign in
Depression during pegylated interferon-alpha plus ribavirin therapy: Prevalence and prediction
Journal article   Open access  Peer reviewed

Depression during pegylated interferon-alpha plus ribavirin therapy: Prevalence and prediction

Charles L RAISON, Andrey S BORISOV, Sherry D BROADWELL, Lucile CAPURON, Bobbi J WOOLWINE, Ira M JACOBSON, Charles B NEMEROFF and Andrew H MILLER
The journal of clinical psychiatry, Vol.66(1), pp.41-48
2005
PMCID: PMC1615913
PMID: 15669887

Abstract

Viral hepatitis Infectious diseases Psychology. Psychoanalysis. Psychiatry Adult and adolescent clinical studies Viral diseases Psychopathology. Psychiatry Mood disorders Biological and medical sciences Depression Medical sciences Human viral diseases
url
https://doi.org/10.4088/JCP.v66n0106View
Published (Version of record) Open

Metrics

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
Citation topics
1 Clinical & Life Sciences
1.125 Hepatitis
1.125.83 HCV
Web Of Science research areas
Psychiatry
Psychology, Clinical
ESI research areas
Psychiatry/Psychology

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Details